Next Issue
Volume 14, 01
Previous Issue
Volume 13, 11
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
0.4
Journals
Cardiovascular Medicine
Volume 13
Issue 12
cardiovascmed-logo

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).

Cardiovasc. Med., Volume 13, Issue 12 (12 2010) – 8 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
1 pages, 136 KB  
Communication
Cardiology Update 2011: Ein Beliebter Treffpunkt für Kardiologen
by Ruth Amstein
Cardiovasc. Med. 2010, 13(12), 384; https://doi.org/10.4414/cvm.2010.01549 - 15 Dec 2010
Viewed by 11
Abstract
Wer «Cardiology Update» einmal besucht hat, kommt bestimmt wieder an diesen einwöchigen Kurs, der das gesamte Gebiet der Kardiologie von den Risikofaktoren bis zur Herztransplantation abdeckt [...] Full article
1 pages, 98 KB  
Communication
Zum Hinschied von Prof. Dr. Med Urs Bauersfeld
by Emanuela Valsangiacomo Büchel and Hans Rickli
Cardiovasc. Med. 2010, 13(12), 383; https://doi.org/10.4414/cvm.2010.01551 - 15 Dec 2010
Viewed by 10
Abstract
Die Mitglieder der Schweizerischen Gesellschaft für Kinderkardiologie und der Schweizerischen Gesellschaft für Kardiologie trauern um Prof. Dr. med [...] Full article
2 pages, 179 KB  
Communication
Zum Hinschied von Prof. Dr. Dr. hc. Walter Siegenthaler
by Thomas F. Lüscher
Cardiovasc. Med. 2010, 13(12), 381; https://doi.org/10.4414/cvm.2010.01548 - 15 Dec 2010
Viewed by 14
Abstract
Walter Siegenthaler, früher Ordinarius für Innere Medizin und Direktor der Medizinischen Poliklinik des UniversitätsSpitals Zürich, ist am Sonntag, dem 24. Oktober 2010, nach einer längeren Krankheit verschieden [...] Full article
3 pages, 336 KB  
Case Report
Renal Arteriovenous Malformation, Hypertension and Heart Failure: Culprit or Confounder?
by Jyotsna Maddury, Venkata M. Allab, Aditya Madhavapeddya, Indrani Garrea and Bhavesh V. Trikamjia
Cardiovasc. Med. 2010, 13(12), 378; https://doi.org/10.4414/cvm.2010.01546 - 15 Dec 2010
Cited by 1 | Viewed by 9
Abstract
Congenital renal arteriovenous malformation (RAVM) is an extremely rare abnormality with about 200 reported cases. It may be asymptomatic and found incidentally, or present with cardiac or renal symptoms. Hence establishing the physiological and clinical significance of RAVM is crucial in identifying patients [...] Read more.
Congenital renal arteriovenous malformation (RAVM) is an extremely rare abnormality with about 200 reported cases. It may be asymptomatic and found incidentally, or present with cardiac or renal symptoms. Hence establishing the physiological and clinical significance of RAVM is crucial in identifying patients in need of treatment and selecting the appropriate treatment. Herein, we report the rare case of a patient presenting with accelerated hypertension, heart failure and a congenital RAVM. We discuss the approach to assessment and treatment of congenital RAVMs in the context of cardiac disease. Full article
2 pages, 181 KB  
Interesting Images
Swinging Heart
by Nina Weber, Christian Steffen and Lars C. Huber
Cardiovasc. Med. 2010, 13(12), 376; https://doi.org/10.4414/cvm.2010.01550 - 15 Dec 2010
Viewed by 8
Abstract
Fallbeschreibung. Ein 31-jähriger, türkischstämmiger Patient stellte sich mit retrosternalem Druck und progredienter Dyspnoe auf unserer Notfallstation vor; aus der Vorgeschichte war ein unklarer, chronischer Perikarderguss bekannt, welcher bisher als nicht punktionswürdig betrachtet wurde [...] Full article
6 pages, 239 KB  
Article
Interventional Cardiology in Switzerland during the Years 2008 and 2009
by Micha T. Maeder, Stephan Windecker, Giovanni Pedrazzini, Marco Roffi, Christoph A. Kaiser, Jean-Christoph Stauffer, Hans Rickli and On behalf of the Working Group “Interventional Cardiology and Acute Coronary Syndrome”
Cardiovasc. Med. 2010, 13(12), 370; https://doi.org/10.4414/cvm.2010.01544 - 15 Dec 2010
Cited by 1 | Viewed by 15
Abstract
Background: Since 1987 a nationwide annual survey of percutaneous cardiac interventions has been performed in Switzerland to assess trends in type and frequency of endovascular cardiac procedures. Methods: The volume and type of endovascular cardiac procedures performed during 2008 and 2009 [...] Read more.
Background: Since 1987 a nationwide annual survey of percutaneous cardiac interventions has been performed in Switzerland to assess trends in type and frequency of endovascular cardiac procedures. Methods: The volume and type of endovascular cardiac procedures performed during 2008 and 2009 were collected by means of a standardised questionnaire to all adult invasive cardiac intervention centres in Switzerland. Results: The number of coronary angiographies (CA; 2008: n = 39 623; +5.7% compared to 2007; 2009: n = 41 592; +4.1%) and percutaneous coronary interventions (PCI; 2008: n = 18 099; +6.0%; 2009: n = 19024; +4.3%) continued to increase with the PCI/CA ratio remaining stable at 45.7% during the study period. After a decrease from 2006 to 2007 the proportion of drug-eluting stents (DES) remained unchanged in 2008 and 2009 (72% of stent-based PCI; 2007: 71%). Emergency PCI for ST-segment elevation myocardial infarction accounted for 20% and 18%, respectively, of PCI in 2008 and 2009 (2007: 22%). The numbers of procedures for closure of patent foramen ovale (2008: n = 619; 2009: n = 728) and atrial septal defect (2008: n = 103; 2009: n = 152) continued to increase. There was a steep increase in the number of transcatheter aortic valve implantations (TAVI; 2007: n = 18; 2008: n = 127; 2009: n = 277) and in the number of centres offering this procedure (2007: n = 1; 2008: n = 7; 2009: n = 8). In 2009, transcatheter mitral valve repair was introduced in Switzerland (33 procedures performed in three centres). Conclusions: Following a plateau in previous years, both CA and PCI procedures expanded in 2008 and 2009 in Switzerland. After a decrease in 2006, the use of DES has remained stable since and accounted for nearly three quarters of stent-based PCI. Percutaneous interventions for structural heart disease are expanding. In particular, TAVI has been rapidly adopted in Switzerland. Full article
7 pages, 755 KB  
Review
Thrombozytenaggregationshemmung Während der Perioperativen Periode
by Ahmed A. Khattab, Ardan M. Saguner and Stephan Windecker
Cardiovasc. Med. 2010, 13(12), 363; https://doi.org/10.4414/cvm.2010.01547 - 15 Dec 2010
Viewed by 10
Abstract
Antiplatelet therapy in form of acetyl salicylic acid (ASA) and/or thienopyridines constitutes a cornerstone in preventing thrombotic complications of coronary artery disease, including stent thrombosis after percutaneous coronary intervention. Premature interruption of dual antiplatelet therapy is one of the most important risk factors [...] Read more.
Antiplatelet therapy in form of acetyl salicylic acid (ASA) and/or thienopyridines constitutes a cornerstone in preventing thrombotic complications of coronary artery disease, including stent thrombosis after percutaneous coronary intervention. Premature interruption of dual antiplatelet therapy is one of the most important risk factors for stent thrombosis, a condition which may often be fatal. Current guidelines recommend dual therapy for at least one year after drug-eluting stents. Antiplatelet therapy is frequently stopped before invasive procedures or noncardiac surgeries because of an increased risk of bleeding complications, which may however lead to life-threatening thrombotic complications. We suggest an algorithm to assist clinicians to choose the suitable regimen for each patient after weighing the risk of stent thrombosis versus the risk of acquiring a bleeding complication. After stratifying the risk for thrombosis into «HIGH» or «NORMAL» according to given criteria, the bleeding risk is then stratified into «HIGH» or «NORMAL». Accordingly, four scenarios for the perioperative antiplatelet therapy exist: dual antiplatelet therapy should be continued perioperatively, ASA should be administered together with short-acting glycoprotein (GP) IIb/IIIa antagonists, ASA only should be continued or both drugs may be stopped. Full article
6 pages, 388 KB  
Editorial
Zahlenmystik Rund Ums Herz—Und Was Daraus zu Lernen Wäre
by Thomas F. Lüscher
Cardiovasc. Med. 2010, 13(12), 357; https://doi.org/10.4414/cvm.2010.01545 - 15 Dec 2010
Cited by 3 | Viewed by 9
Abstract
Die ersten Zahlen. Zahlen waren gleich zu Beginn der interventionellen Kardiologie wichtig: An seinen legendären Kursen am UniversitätsSpital Zürich Ende der 1970er und zu Beginn der 1980er Jahre (Abb. 1) notierte Andreas Grüntzig auf der Wandtafel des Hörsaals Nord die Anzahl perkutaner koronarer [...] Read more.
Die ersten Zahlen. Zahlen waren gleich zu Beginn der interventionellen Kardiologie wichtig: An seinen legendären Kursen am UniversitätsSpital Zürich Ende der 1970er und zu Beginn der 1980er Jahre (Abb. 1) notierte Andreas Grüntzig auf der Wandtafel des Hörsaals Nord die Anzahl perkutaner koronarer Interventionen (PCI), welche weltweit seit seinem ersten Eingriff vorgenommen worden waren [...] Full article
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-8
Previous Issue
Next Issue
Back to TopTop